Drug Profile
Research programme: STAT3 transcription factor inhibitors - Singh Biotechnology
Alternative Names: SBT 100; SBT 101Latest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator Singh Biotechnology
- Class Antineoplastics; Single-domain antibodies
- Mechanism of Action STAT3 transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer